Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Site, Placebo Controlled, Double Blind Randomised Clinical Trial Evaluating the Effectiveness of Metformin to Prevent Post-transplant Diabetes in a Cohort of Patients Undergoing Renal Transplantation

NCT05240274 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.

NCT NCT05240274
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05240274 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Site, Placebo Controlled, Double Blind Randomised Clinical Trial Evaluating the Effectiveness of Metformin to Prevent Post-transplant Diabetes in a Cohort of Patients Undergoing Renal Transplantation
Lead sponsor
Barts & The London NHS Trust
Phase
Phase 2
Overall status
Completed
Start date
January 25, 2019
Completion date
August 30, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, kidney transplant; complications, metformin, new onset diabetes after transplant, new onset diabetes after transplantation, post-transplant diabetes mellitus, renal transplantation